Dennis Reilly - Net Worth and Insider Trading
Dennis Reilly Net Worth
The estimated net worth of Dennis Reilly is at least $47 dollars as of 2024-06-08. Dennis Reilly is the CFO of Agile Therapeutics Inc and owns about 126 shares of Agile Therapeutics Inc (AGRX) stock worth over $47. Details can be seen in Dennis Reilly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dennis Reilly has not made any transactions after 2021-07-27 and currently still holds the listed stock(s).
Transaction Summary of Dennis Reilly
Dennis Reilly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Reilly owns 1 companies in total, including Agile Therapeutics Inc (AGRX) .
Click here to see the complete history of Dennis Reilly’s form 4 insider trades.
Insider Ownership Summary of Dennis Reilly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGRX | Agile Therapeutics Inc | 2021-07-27 | Chief Financial Officer |
Dennis Reilly Latest Holdings Summary
Dennis Reilly currently owns a total of 1 stock. Dennis Reilly owns 126 shares of Agile Therapeutics Inc (AGRX) as of July 27, 2021, with a value of $47.
Latest Holdings of Dennis Reilly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGRX | Agile Therapeutics Inc | 2021-07-27 | 126 | 0.37 | 47 |
Holding Weightings of Dennis Reilly
Dennis Reilly Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Reilly has made a total of 4 transactions in Agile Therapeutics Inc (AGRX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Agile Therapeutics Inc is the acquisition of 25 shares on July 27, 2021, which cost Dennis Reilly around $54,000.
Insider Trading History of Dennis Reilly
- 1
Dennis Reilly Trading Performance
GuruFocus tracks the stock performance after each of Dennis Reilly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis Reilly is -7.45%. GuruFocus also compares Dennis Reilly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis Reilly within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis Reilly's insider trading performs compared to the benchmark.
Performance of Dennis Reilly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.69 | | | | | |
| Relative Return to S&P 500(%) | -2.36 | | | | | |
Dennis Reilly Ownership Network
Dennis Reilly Owned Company Details
What does Agile Therapeutics Inc do?
Who are the key executives at Agile Therapeutics Inc?
Dennis Reilly is the Chief Financial Officer of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and director & Chief Executive Officer Alfred Altomari .
Agile Therapeutics Inc (AGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agile Therapeutics Inc Insider Transactions
Dennis Reilly Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Reilly. You might contact Dennis Reilly via mailing address: 600 College Road East, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
